Brennan VK, Mauskopf JA, Colosia AD, Copley-Merriman K, Hass B, Palencia R. Utility estimates for patients with type 2 diabetes mellitus after experiencing a myocardial infarction or stroke: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015 Feb;15(1):111-23.
Brennan VK, Colosia AD, Copley-Merriman K, Mauskopf J, Haas B, Psalencia R. Incremental costs associated with myocardial infarction and stroke in patients with type 2 diabetes mellitus: an overview for economic modeling. J Med Econ. 2014 Jul;17(7):469-80. doi: 10.3111/13696998.2014.915847
Brennan VK, Colosia AD, Copley-Merriman C, Hass B, Palencia R. Systematic literature review of costs related to patients with type 2 diabetes mellitus experiencing a stroke or myocardial infarction. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 7, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A162. doi: 10.1016/j.jval.2013.03.811
Brennan VK, Colosia AD, Copley-Merriman C, Hass B, Palencia R. Systematic literature review of utilities relating to patients with type-2 diabetes mellitus experiencing a stroke or myocardial infarction. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A168. doi: 10.1016/j.jval.2013.03.841
Caro JJ, Klittich WS, Raggio G, Kavanagh PL, O'Brien JA, Shomphe LA, Flegel KM, Copley-Merriman C, Sigler C. Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes. Clin Ther. 2000 Jan;22(1):116-27.